A New Frontier: Cord Blood Stem Cells in the Treatment of Crohn’s Disease

A groundbreaking study has explored the potential of using autologous cord blood stem cells for treating refractory Crohn’s Disease – a condition where standard treatments fail to manage symptoms. The trial evaluated the long-term effects of using a patient’s own stored cord blood stem cells.  The results were highly promising, with a significant percentage of patients showing improvement and a notable reduction in symptoms and many patients achieving remission.

Read the full study here.